CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-05-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $11.37 | $114K | 2,485 |
| 2024-05-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 70,000 | ||
| 2024-04-17 | Skorpios Trust 10% owner | Sale | −3,600,000 | $11.60 | $41.8M | 10,843,681 |
| 2024-04-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +442 | $0.60 | $265 | 11,911 |
| 2024-04-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −9,426 | $13.23 | $125K | 2,485 |
| 2024-04-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −442 | 80,000 | ||
| 2024-04-01 | Nash Huw M. COO & CBO | Option exercise 10b5-1 | +50,000 | $0.40 | $20K | 61,329 |
| 2024-04-01 | Nash Huw M. COO & CBO | Sale 10b5-1 | −60,929 | $13.22 | $806K | 400 |
| 2024-04-01 | Nash Huw M. COO & CBO | Sale 10b5-1 | −400 | $13.61 | $5K | 0 |
| 2024-04-01 | Nash Huw M. COO & CBO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 96,000 | ||
| 2024-03-28 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −5,026 | $13.19 | $66K | 2,698 |
| 2024-03-28 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −100 | $13.81 | $1K | 2,598 |
| 2024-03-27 | Kaye Edward M. MD CEO | Grant or award · Employee Stock Option (Right to Buy) | +159,000 | 159,000 | ||
| 2024-03-27 | Kaye Edward M. MD CEO | Grant or award · Restricted Stock Units | +105,000 | 105,000 | ||
| 2024-03-27 | Nash Huw M. COO & CBO | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-03-27 | Nash Huw M. COO & CBO | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2024-03-27 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-03-27 | Ticho Barry CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2024-03-27 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Employee Stock Option (Right to Buy) | +36,000 | 36,000 |
Page 17 of 24 · 461 trades